PLG and cardiac hypertrophy: Furthermore, uPA and plasmin have also been shown to mediate the development of cardiac hypertrophy and fibrosis induced by experimental treatments such as transverse aorta constriction (widely used as a model for aortic stenosis), hypoxia or pharmacologically induced hypertension78–82.